AI-Guided Intensified Follow-up After Surgery for Acute Type A Aortic Dissection
AIMS-ATAAD-FU
Artificial Intelligence Multimodal Prediction Model-Guided Intensified Follow-up Strategy for 1-Year Outcomes After Surgery for Acute Type A Aortic Dissection: A Multicenter Randomized Controlled Trial
1 other identifier
interventional
1,314
0 countries
N/A
Brief Summary
This multicenter, prospective, randomized controlled trial will evaluate whether an artificial intelligence (AI) multimodal prediction model-guided intensified follow-up strategy improves 1-year outcomes after surgery for acute Stanford type A aortic dissection. Eligible adult patients who have undergone open surgical repair or open plus endovascular/hybrid repair and are clinically stable to enter the postoperative follow-up phase will be randomized 1:1 to usual postoperative follow-up or AI-guided intensified follow-up. The AI-guided arm will receive usual follow-up plus an AI-generated risk stratification report for 1-year mortality and adverse aortic remodeling. Higher-risk patients may receive more frequent follow-up, prioritized CTA review, multidisciplinary assessment, and targeted management reminders. The primary outcome is all-cause mortality through postoperative day 365. Key secondary outcomes include aortic reintervention, adverse aortic remodeling, and ICU readmission within 1 year.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Dec 2026
Typical duration for not_applicable
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
May 29, 2026
CompletedFirst Posted
Study publicly available on registry
June 3, 2026
CompletedStudy Start
First participant enrolled
December 1, 2026
ExpectedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2028
Study Completion
Last participant's last visit for all outcomes
December 1, 2029
June 3, 2026
May 1, 2026
2 years
May 29, 2026
May 29, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
All-Cause Mortality Within 365 Days After Surgery
The proportion of randomized participants who die from any cause from randomization through postoperative day 365. Death status will be ascertained from hospital medical records, follow-up contacts, death registry information when available, and adjudicated by a blinded Clinical Event
From randomization to postoperative day 365
Secondary Outcomes (6)
Aortic Reintervention Within 365 Days After Surgery
From randomization to postoperative day 365
Adverse Aortic Remodeling Within 365 Days After Surgery
From randomization to postoperative day 365
ICU Readmission Within 365 Days After Surgery
From randomization to postoperative day 365
Aorta-Related Mortality Within 365 Days After Surgery
From randomization to postoperative day 365
Unplanned Hospital Readmission Within 365 Days After Surgery
From randomization to postoperative day 365
- +1 more secondary outcomes
Study Arms (2)
Usual Postoperative Follow-up Strategy
ACTIVE COMPARATORParticipants will receive the existing postoperative follow-up pathway at each center after ATAAD repair, including routine discharge education, blood pressure and medication management, outpatient or telephone follow-up, CTA or ultrasound follow-up according to center practice, and management of abnormal findings through routine clinical pathways. AI risk stratification reports will not be provided to the clinical team in this arm, except for ethically required safety information if applicable.
AI Prediction Model-Guided Intensified Follow-up Strategy.
EXPERIMENTALParticipants will receive usual postoperative follow-up plus AI-generated risk stratification for 1-year mortality and adverse aortic remodeling. The risk report will classify participants as low, moderate, high, or very high risk. Higher-risk participants may receive more frequent follow-up, earlier or prioritized CTA review, active telephone tracking, multidisciplinary team discussion, rapid review of abnormal imaging findings, and reintervention risk assessment. The AI report is auxiliary and does not replace physician judgment.
Interventions
Routine postoperative surveillance and management after acute type A aortic dissection repair according to each center's standard clinical practice.
Use of a previously developed AI multimodal prediction model to generate risk stratification for postoperative 1-year mortality and adverse aortic remodeling, triggering protocolized intensified follow-up actions when indicated.
Eligibility Criteria
You may qualify if:
- \. Age 18 years or older. 2. Acute Stanford type A aortic dissection confirmed by CTA, intraoperative findings, or medical records.
- \. Underwent open surgical repair or open repair combined with endovascular/hybrid repair.
- \. Postoperative condition is stable and the patient is planned for discharge or has entered early post-discharge follow-up.
- \. Core baseline data required for AI model operation are available, including at least one eligible preoperative or postoperative CTA imaging dataset.
- \. Able to complete telephone, outpatient, or inpatient follow-up and willing to provide written informed consent.
You may not qualify if:
- \. Predominantly chronic type A dissection, traumatic dissection, or iatrogenic dissection, if the investigator judges the patient unsuitable for this follow-up strategy study.
- \. Did not undergo surgical repair, received only palliative treatment, or did not meet postoperative randomization conditions.
- \. Expected inability to complete 12-month follow-up, no stable contact information, or inability to obtain outpatient, telephone, or inpatient follow-up data.
- \. Severe missing baseline data preventing generation of the AI risk report. 5. Concurrent participation in another interventional study that may substantially affect postoperative follow-up intensity or the primary outcome.
- \. Any other condition that, in the investigator's judgment, makes the patient unsuitable for participation.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- The Affiliated Hospital of Qingdao Universitycollaborator
- Guangdong Provincial People's Hospitalcollaborator
- Wuhan Asia Heart Hospitalcollaborator
- Tongji Hospitalcollaborator
- Renmin Hospital of Wuhan Universitycollaborator
- Beijing Anzhen Hospitalcollaborator
- Sir Run Run Shaw Hospitalcollaborator
- Second Affiliated Hospital, School of Medicine, Zhejiang Universitylead
- The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical Schoolcollaborator
- Union Hospital, Tongji Medical College, Huazhong University of Science and Technologycollaborator
Related Publications (6)
Zhu Y, Xu XY, Rosendahl U, Pepper J, Mirsadraee S. Prediction of aortic dilatation in surgically repaired type A dissection: A longitudinal study using computational fluid dynamics. JTCVS Open. 2022 Feb 9;9:11-27. doi: 10.1016/j.xjon.2022.01.019. eCollection 2022 Mar.
PMID: 36003481BACKGROUNDShad R, Kong S, Fong R, Quach N, Kasinpila P, Bowles C, Lee A, Hiesinger W. Computational Fluid Dynamics Simulations to Predict False Lumen Enlargement After Surgical Repair of Type-A Aortic Dissection. Semin Thorac Cardiovasc Surg. 2022 Summer;34(2):443-448. doi: 10.1053/j.semtcvs.2021.05.012. Epub 2021 Jun 3.
PMID: 34091015BACKGROUNDNappi F, Gambardella I, Singh SSA, Salsano A, Santini F, Spadaccio C, Biancari F, Dominguez J, Fiore A. Survival following acute type A aortic dissection: a multicenter study. J Thorac Dis. 2023 Dec 30;15(12):6604-6622. doi: 10.21037/jtd-23-1137. Epub 2023 Dec 21.
PMID: 38249919BACKGROUNDGemelli M, Di Tommaso E, Chivasso P, Sinha S, Ahmed EM, Rajakaruna C, Bruno VD. Blood lactate predicts mortality after surgical repair of type A acute aortic dissection. J Card Surg. 2022 May;37(5):1206-1211. doi: 10.1111/jocs.16324. Epub 2022 Feb 13.
PMID: 35152486BACKGROUNDZhou T, Li JX, Zhang CY, Li YG, Peng J, Wei CL, Chen MH, Zhou HF. Risk factors for one-year mortality following discharge in patients with acute aortic dissection: development and validation of a predictive model in a cross-sectional study. BMC Cardiovasc Disord. 2024 Feb 29;24(1):129. doi: 10.1186/s12872-024-03766-6.
PMID: 38424525BACKGROUNDYang Y, Xue J, Li H, Tong J, Jin M. Perioperative risk factors predict one-year mortality in patients with acute type-A aortic dissection. J Cardiothorac Surg. 2020 Sep 11;15(1):249. doi: 10.1186/s13019-020-01296-8.
PMID: 32917250BACKGROUND
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Masking Details
- Single masking: Outcomes Assessor. The Clinical Event Committee and imaging core laboratory outcome review will be blinded to treatment allocation where feasible. Participants and treating clinical teams will not be blinded because follow-up intensity differs by group.
- Purpose
- HEALTH SERVICES RESEARCH
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal Investigator
Study Record Dates
First Submitted
May 29, 2026
First Posted
June 3, 2026
Study Start (Estimated)
December 1, 2026
Primary Completion (Estimated)
December 1, 2028
Study Completion (Estimated)
December 1, 2029
Last Updated
June 3, 2026
Record last verified: 2026-05
Data Sharing
- IPD Sharing
- Will not share
Individual participant data will not be shared publicly. This multicenter trial collects sensitive postoperative clinical data, laboratory results, surgical information, CTA/DICOM imaging data, AI model outputs, and follow-up outcomes from patients with acute type A aortic dissection. Data will be managed using coded study identifiers, and the linkage between study ID and personal identity will be retained only at each participating center. Access to source data will be limited to authorized investigators, study monitors, ethics committees, and regulatory authorities when required. Any future data sharing would require additional institutional approval, ethics approval, and appropriate data use agreements.